Andrew (Andy) Cochran is a partner in the New York office of Cahill Gordon & Reindel LLP.
While Andy has a versatile range of experience in high-stakes patent matters involving a variety of technologies, including enterprise content management software, enterprise file sharing and sync software, microchip technology, and medical devices, he focuses his practice mainly on complex patent litigation matters involving pharmaceuticals, biotechnology, and biologics/biosimilars both in federal court and before the Patent Trial and Appeal Board of the U.S. Patent Office. Andy also has an extensive patent prosecution background that has encompassed an array of technologies, including automotive hybrid systems, medical devices, consumer products, and oncology.
Andy is a contributor to the “Intellectual Property Issues for Pharmaceutical Manufacturers” chapter in Fastcase’s Regulation of Pharmaceutical Manufacturers (2020). Andy was also featured in the 2024 edition of Best Lawyers’ “Ones to Watch” in the area of patent litigation.
Matters
*Matter handled prior to joining Cahill.
Professional Activities:
Associations